Eliza, a health engagement management and member analytics firm, serves more than 70 healthcare organizations, including eight of the top 10 health plans in the United States. Eliza uses behavioral science and predictive analytics to identify gaps in care and retain members. Its product focuses include quality of care, consumer experience, revenue management and membership growth.
Eliza has more than 50 domestic and international patents and patent applications, which HMS will acquire.
“Payers are seeking reliable insights and actionable information to manage risk and improve the quality of care delivered,” said Bill Lucia, chairman and CEO of HMS. “The addition of Eliza will position HMS to impact both revenue and costs for our health plan customers, while continuing to supply needed tools to more effectively manage the care of their members across all markets.”
The transaction is expected to close by the second quarter of 2017, subject to regulatory approvals and other closing conditions.
More articles on health IT:
AHIMA releases health IT guidelines to support LGBT patients
Almost 18k records exposed in Metropolitan Urology Group ransomware attack
Insiders responsible for 58% of healthcare data breaches in February: 5 insights
